Glenbrook Capital Management has significantly increased its exposure to SenesTech Inc. (NASDAQ: SNES) through a calculated series of open market purchases. Acting as the investment manager for an account holding a ten percent stake in the company, the fund acquired 25,416 shares of SenesTech common stock over a concentrated four-day period in late June 2026. The total value of these transactions reached $39,102, with shares purchased at prices ranging from $1.5244 to $1.5558 per unit.
This accumulation occurred while the stock was trading near its 52-week low of $1.41, a level that reflects a substantial 71% decline over the past year. According to InvestingPro analysis, the current valuation suggests the stock may be undervalued, indicating potential upside for investors monitoring the pest control and agricultural inputs sector. The transactions were executed on June 24, 2026, with 3,990 shares acquired; followed by 9,442 shares on June 25; 6,812 shares on June 26; and concluding with 5,172 shares on June 29.
Following these purchases, Glenbrook Capital Management holds a total of 987,824 shares of SenesTech's common stock indirectly. The reporting entity disclaims beneficial ownership except to the extent of its pecuniary interest. This activity highlights the fund's continued confidence in SenesTech's long-term prospects despite recent market headwinds.
SenesTech's operational performance has shown recent improvements that may underpin this institutional interest. The company reported a modest 2% increase in revenue for the first quarter of 2026, reaching $493,000 compared to $485,000 in the same period last year. More notably, SenesTech achieved a record gross margin of 68.6%, an improvement from 64.5% in the first quarter of 2025. To support further growth, the company appointed Jack Karabees as Executive Vice President of Sales. Karabees brings over 30 years of experience in B2B sales organizations and is expected to bolster revenue growth, market expansion, and customer relationships.
Strategic expansion efforts also include a new distribution agreement with Animal and Garden House to introduce Evolve Rodent Birth Control products to the Bermuda market. This entry is significant as traditional rodenticides face regulatory restrictions in Bermuda due to environmental concerns, positioning SenesTech's biological solutions as a viable alternative. Additionally, the Board of Directors amended a proposal to increase shares available under its 2018 Equity Incentive Plan, reducing the requested amount from 1.7 million shares to 1.2 million shares. This amended proposal will be presented to stockholders for approval in June 2026, reflecting ongoing efforts to optimize financial strategies and align equity compensation with shareholder interests.